SecBot SecBot
8-K ·Filed Nov 5, 2026

PRVA

Privia Health Group, Inc.
MIXED
Impact 6/10
Horizonweeks Processed11d 20h ago SEC0001759655-26-000083
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The EPS miss is stark but the raised guidance and acquisition signal operational confidence. Activist presence adds pressure for margin improvement and capital allocation. Watch the Q3 10-Q filing for segment detail and the conference call for commentary on the Montana exit and integration of the American Choice acquisition.

DirectionMixed
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Privia Health reported Q3 2026 revenue of $657.0M (+13.2% YoY) and GAAP diluted EPS of $0.10, below the consensus estimate of $0.24. The company raised full-year 2026 guidance above the high end for all key financial metrics, acquired American Choice Healthcare MSSP for ~$36M, and announced an exit from its Montana partnership. The EPS miss is significant, but the raised guidance and strong operating metrics (Adjusted EBITDA +6.3% YoY) provide a mixed picture, with activist investor pressure from a September SC 13D adding context.

Key Financial Metrics

EPS
$0.10
est $0.24 · -58.3%
Revenue
$657.0M
est $610.6M · +7.6% · +13.2% YoY
Rating
in line
Guidance
$2.5B-$2.55B
raised
Gross Margin
20.5%

Key Facts

  • Q3 2026 revenue $657.0M, +13.2% YoY from $580.4M
  • GAAP diluted EPS $0.10 vs consensus $0.24 (miss of -58.3%)
  • Non-GAAP adjusted diluted EPS $0.21 vs $0.19 YoY (+10.5%)
  • Full-year 2026 guidance raised: GAAP revenue to $2.5B-$2.55B (from $2.35B-$2.45B), Adjusted EBITDA to $154M-$157M (from $145M-$155M)
  • Acquired American Choice Healthcare MSSP for ~$36M in cash, adding 36,000+ attributed lives
  • Exiting Montana partnership effective Jan 2027, impacting 69 providers and ~$23M annual Practice Collections
  • Cash and equivalents $446.3M, no debt; expects to end year with at least $520M cash
  • Activist investor (Puma Growth Holdings/Rubicon Founders) filed SC 13D on Sept 8, 2026

Financial Impact

Q3 EPS miss of ~$0.14 vs consensus; revenue beat of ~$46.4M vs $610.6M consensus; raised FY guidance implies ~$150M incremental revenue at midpoint

revenueepsguidancecash

Risk Factors

  • GAAP EPS of $0.10 significantly below consensus of $0.24, driven by high stock-based compensation ($14.0M in Q3) and tax provision
  • Montana partnership exit removes ~$23M in annual Practice Collections, though management expects no material EBITDA impact
  • Activist investor (SC 13D filed Sept 8) may push for strategic changes or cost cuts
  • Cash flow from operations negative $19.4M YTD due to working capital build (accounts receivable +$221.8M)
  • Integration risk from American Choice Healthcare acquisition

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services
Analyst Consensus
92% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001759655-26-000083
Document: prva-20261105.htm0001759655-26-000083
Document: 0001759655-26-000083-index-headers.html0001759655-26-000083
Document: 0001759655-26-000083-index.html0001759655-26-000083
Document: 0001759655-26-000083.txt0001759655-26-000083
8-K Data (Synthetic)0001759655-26-000083

Track record

20 reports on PRVA

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +10.73% at T+60 after the Mar 9, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Mixed 6/10 Viewing No price data
  2. Nov 5, 202611d ago Press Release Bearish 5/10 Entry $23.94 to $23.67 Now $25.26 −5.51% ▲ +1.13% +4.42% vs SPY
  3. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $21.28 to $24.54 Now $25.26 +18.70% ▲ +15.32% +15.24% vs SPY
  4. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $21.48 to $24.42 Now $25.26 +17.60% ▲ +13.69% +16.39% vs SPY
  5. Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $20.30 to $21.67 Now $25.26 +24.43% ▲ +6.75% +7.73% vs SPY
  6. Jul 13, 202618w ago Insider Cluster Neutral 3/10 Entry $28.03 to $26.26 Now $25.26 −9.88% ▼ −6.31% −5.02% vs SPY
  7. Jul 9, 202618w ago Insider Cluster Neutral 3/10 Entry $27.49 to $26.90 Now $25.26 −8.11% ▼ −2.15% −0.60% vs SPY
  8. Jul 7, 202618w ago Insider Cluster Neutral 3/10 Entry $27.21 to $28.10 Now $25.26 −7.17% ▲ +3.27% +2.01% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 1/10 Entry $27.23 to $28.03 Now $25.26 −7.23% ▲ +2.94% +2.39% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Neutral 3/10 Entry $27.36 to $27.77 Now $25.26 −7.68% ▲ +1.50% +0.57% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026